Q2 2026 Earnings Call January 29, 2026 4:00 AM ESTCompany ParticipantsDennis Schulz - CEO & DirectorSimon Bourne - CTO ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2025 Earnings Call Transcript January 30, 2026 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $11.44, expectations were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results